Right vEntricular Dysfunction in tEtralogy of Fallot: INhibition of the rEnin-angiotensin-aldosterone system (REDEFINE) trial: Rationale and design of a randomized, double-blind, placebo-controlled clinical trial
Jouke P. Bokma, Michiel M. Winter, Esmée M. Kornaat, Hubert W. Vliegen, Arie P. van Dijk, Joost P. van Melle, Folkert J. Meijboom, Martijn C. Post, Jacqueline K. Berbee, Aeilko H. Zwinderman, Barbara J.M. Mulder, Berto J. Bouma*
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Right vEntricular Dysfunction in tEtralogy of Fallot: INhibition of the rEnin-angiotensin-aldosterone system (REDEFINE) trial: Rationale and design of a randomized, double-blind, placebo-controlled clinical trial'. Together they form a unique fingerprint.